In NSCLC patients, expression of IL33 and IL1RL1 was found to be increased in tumor tissue compared to adjacent non-tumor tissue, and this expression was associated with disease clinical stage (43). The gene discussed is IL33; the disease is non-small cell lung carcinoma.